Minimed Group, Inc.
MMED
$19.78
$0.281.44%
NASDAQ
| 04/24/2026 | 01/23/2026 | 10/24/2025 | 07/24/2025 | ||
|---|---|---|---|---|---|
| Revenue | 15.61% | 14.99% | 13.11% | 13.11% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 15.61% | 14.99% | 13.11% | 13.11% | |
| Cost of Revenue | 12.26% | 44.52% | 10.40% | 10.40% | |
| Gross Profit | 18.23% | -6.84% | 15.27% | 15.27% | |
| SG&A Expenses | 8.33% | 15.30% | 7.28% | 7.28% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | 233.33% | 557.14% | 240.00% | 240.00% | |
| Total Operating Expenses | 10.84% | 31.88% | 9.81% | 9.81% | |
| Operating Income | 118.75% | -495.45% | 195.24% | 195.24% | |
| Income Before Tax | 36.99% | -571.43% | 110.00% | 110.00% | |
| Income Tax Expenses | 342.86% | -57.14% | 666.67% | 666.67% | |
| Earnings from Continuing Operations | -10.78% | -1,485.71% | 8.70% | 8.70% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | 100.00% | -166.67% | 0.00% | 0.00% | |
| Net Income | -7.56% | -1,090.00% | 6.45% | 6.45% | |
| EBIT | 118.75% | -495.45% | 195.24% | 195.24% | |
| EBITDA | 55.71% | -181.36% | 108.51% | 108.51% | |
| EPS Basic | -1.40% | -1,088.64% | -- | -- | |
| Normalized Basic EPS | 179.09% | -710.75% | -- | -- | |
| EPS Diluted | -1.72% | -1,088.64% | -- | -- | |
| Normalized Diluted EPS | 179.09% | -710.75% | -- | -- | |
| Average Basic Shares Outstanding | 6.07% | 0.00% | -- | -- | |
| Average Diluted Shares Outstanding | 6.07% | 0.00% | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |